Cargando…

Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis

BACKGROUND/AIMS: Premature degradation of mutated cystic fibrosis transmembrane conductance regulator (CFTR) protein causes cystic fibrosis (CF), the commonest Mendelian disease in Caucasians. Despite recent advances in precision medicines for CF patients, many CFTR mutants have not been characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopes-Pacheco, Miquéias, Boinot, Clément, Sabirzhanova, Inna, Rapino, Daniele, Cebotaru, Liudmila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082854/ https://www.ncbi.nlm.nih.gov/pubmed/28448979 http://dx.doi.org/10.1159/000475578

Ejemplares similares

Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation
por: Rapino, Daniele, et al.
Publicado: (2015)

Syntaxin 8 and the Endoplasmic Reticulum Processing of ΔF508-CFTR
por: Sabirzhanova, Inna, et al.
Publicado: (2018)

Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR
por: Cebotaru, Liudmila, et al.
Publicado: (2014)

Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease
por: Yanda, Murali K., et al.
Publicado: (2021)

Bithiazole Correctors Rescue CFTR Mutants by Two Different Mechanisms
por: Loo, Tip W., et al.
Publicado: (2013)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021)

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
por: Spanò, Virginia, et al.
Publicado: (2021)

Functional Rescue of F508del-CFTR Using Small Molecule Correctors
por: Molinski, Steven, et al.
Publicado: (2012)

Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2022)

Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
por: Pedemonte, Nicoletta, et al.
Publicado: (2020)

Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
por: Renda, Mario, et al.
Publicado: (2023)

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
por: Capurro, Valeria, et al.
Publicado: (2021)

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors
por: Righetti, Giada, et al.
Publicado: (2020)

Syntaxin 6 and CAL Mediate the Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator
por: Cheng, Jie, et al.
Publicado: (2010)

Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
por: Amico, Giulia, et al.
Publicado: (2019)

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
por: Devesa, Isabel, et al.
Publicado: (2013)

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
por: Brandas, Chiara, et al.
Publicado: (2021)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
por: Gentzsch, Martina, et al.
Publicado: (2021)

Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
por: Laselva, Onofrio, et al.
Publicado: (2021)

Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine
por: Matthes, Elizabeth, et al.
Publicado: (2018)

Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs
por: Abu-Arish, Asmahan, et al.
Publicado: (2022)

Computational Exploration of Potential CFTR Binding Sites for Type I Corrector Drugs
por: Lester, Anna, et al.
Publicado: (2023)

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
por: Bagdany, Miklos, et al.
Publicado: (2017)

Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D
por: Carotti, Marcello, et al.
Publicado: (2018)

Translating in vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network‐based Cellular Signatures drug discovery platform
por: Strub, Matthew D., et al.
Publicado: (2021)

Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
por: Baatallah, Nesrine, et al.
Publicado: (2022)

Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking
por: Coffman, Keith C., et al.
Publicado: (2014)

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
por: Odolczyk, Norbert, et al.
Publicado: (2013)

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
por: Carotti, Marcello, et al.
Publicado: (2020)

CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3
por: Scano, Martina, et al.
Publicado: (2021)

Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain–domain coupling
por: Soya, Naoto, et al.
Publicado: (2023)

Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants
por: McDonald, Eli Fritz, et al.
Publicado: (2022)

Transmembrane helical interactions in the CFTR channel pore
por: Das, Jhuma, et al.
Publicado: (2017)

Unravelling druggable signalling networks that control F508del-CFTR proteostasis
por: Hegde, Ramanath Narayana, et al.
Publicado: (2015)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90
por: Prota, Luiz Felipe M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gotb9mtsu6v17t61slto8s842k